Product Information
MIDAZOLAM HCL 10 MG/2 ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.5053 per ML under NDC 00641606325. Its NADAC has been published 63 times since Jul 23, 2025.
FDA first approved this application on Jun 20, 2000. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641606325
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
2/18/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075243FDA Approved
6/20/2000
TE Code
AP
On Market Since
6/20/2000
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has been published 63 times since Jul 23, 2025, and over the history we have for it it has declined 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5053 per ML |
|---|---|
| All-time high | $0.5265 (Dec 10, 2025) |
| All-time low | $0.5053 (Feb 18, 2026) |
| 52-week high | $0.5265 |
| 52-week low | $0.5053 |
| Median price | $0.5053 |
| Average price | $0.5137 |
| Largest weekly change | -2.7% (Feb 18, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Midazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 10 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 10 MG/2 ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $0.5053 per ML (NDC 00641606325), effective Sep 30, 2026.
How has the price of MIDAZOLAM HCL 10 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has declined 3.6%. It has been tracked across 63 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 10 MG/2 ML VIAL?
Since Jul 23, 2025, the NADAC for MIDAZOLAM HCL 10 MG/2 ML VIAL has ranged from a low of $0.5053 (Feb 18, 2026) to a high of $0.5265 (Dec 10, 2025), with a median of $0.5053 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 10 MG/2 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDAZOLAM HCL 50 MG/10 ML VIAL, is $0.3817 per ML — about 24% below MIDAZOLAM HCL 10 MG/2 ML VIAL.
Who manufactures MIDAZOLAM HCL 10 MG/2 ML VIAL?
MIDAZOLAM HCL 10 MG/2 ML VIAL (NDC 00641606325) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.